Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Metadoxine improves the three- and six-month survival rates in patients with severe alcoholic hepatitis.
World J Gastroenterol. 2015 Apr 28;21(16):4975-85. doi: 10.3748/wjg.v21.i16.4975.
World J Gastroenterol. 2015.
PMID: 25945012
Free PMC article.
Clinical Trial.
Treatment with metadoxine and its impact on early mortality in patients with severe alcoholic hepatitis.
Higuera-de la Tijera F, Servín-Caamaño AI, Cruz-Herrera J, Serralde-Zúñiga AE, Abdo-Francis JM, Gutiérrez-Reyes G, Pérez-Hernández JL.
Higuera-de la Tijera F, et al. Among authors: cruz herrera j.
Ann Hepatol. 2014 May-Jun;13(3):343-52.
Ann Hepatol. 2014.
PMID: 24756009
Free article.
Clinical Trial.
Item in Clipboard
Comorbidities and polypharmacy among HIV-positive patients aged 50 years and over: a case-control study.
Mata-Marín JA, Martínez-Osio MH, Arroyo-Anduiza CI, Berrospe-Silva MLÁ, Chaparro-Sánchez A, Cruz-Grajales I, Cruz-Herrera JE, Uribe-Noguez LA, Gaytán-Martínez JE, Jerónimo-Morales M.
Mata-Marín JA, et al. Among authors: cruz herrera je.
BMC Res Notes. 2019 Sep 3;12(1):556. doi: 10.1186/s13104-019-4576-6.
BMC Res Notes. 2019.
PMID: 31481133
Free PMC article.
Item in Clipboard
Effectiveness of etravirine-based therapy for treatment-experienced HIV-infected patients.
Huerta García G, Mata-Marín JA, Domínguez-Hermosillo JC, Chavez-García M, Banda-Lara MI, Nuñez-Rodríguez N, Cruz-Herrera JE, Sandoval-Ramírez JL, Villagómez-Ruiz A, Manjarrez-Tellez B, Gaytan-Martínez JE.
Huerta García G, et al. Among authors: cruz herrera je.
J Infect Dev Ctries. 2016 Jun 30;10(6):605-11. doi: 10.3855/jidc.7512.
J Infect Dev Ctries. 2016.
PMID: 27367009
Free article.
Item in Clipboard
Effectiveness and risk factors for virological outcome of darunavir-based therapy for treatment-experienced HIV-infected patients.
Mata-Marín JA, Huerta-García G, Domínguez-Hermosillo JC, Chavez-García M, Banda-Lara MI, Nuñez-Rodríguez N, Cruz-Herrera JE, Sandoval-Ramírez JL, Martínez-Abarca I, Villagómez-Ruíz AF, Manjarrez-Tellez B, Gaytán-Martínez J.
Mata-Marín JA, et al. Among authors: cruz herrera je.
AIDS Res Ther. 2015 Sep 24;12:31. doi: 10.1186/s12981-015-0072-9. eCollection 2015.
AIDS Res Ther. 2015.
PMID: 26413132
Free PMC article.
Item in Clipboard
Cite
Cite